Literature DB >> 1351267

Selective vulnerability of hippocampal CA1 neurons cannot be explained in terms of an increase in glutamate concentration during ischemia in the gerbil: brain microdialysis study.

A Mitani1, Y Andou, K Kataoka.   

Abstract

Ischemia-induced selective neuronal injury to field CA1 is not attributable to selective glutamate release in field CA1 during ischemia. Excessive release of glutamate has been proposed to play a major role in ischemia-induced selective neuronal death in field CA1 of the hippocampus. It is well known that, following carotid arterial occlusion of 5 min duration in the gerbil, the pyramidal neurons in field CA1 show delayed neuronal death, whereas the neurons in field CA3 do not show any neuronal degeneration. In the present study, we measured the levels of released glutamate during ischemia in field CA1 and field CA3, separately, and evaluated whether there are subregional differences in the concentration of released glutamate which could be a satisfactory explanation for the selective vulnerability of hippocampal neurons to ischemia. Extracellular glutamate levels were significantly increased during ischemia in both field CA1 and field CA3. No significant differences were detected in the time-course of change in glutamate release and the levels of glutamate between field CA1 and field CA3. This result indicates that the increased glutamate levels do not play a pivotal part in the detrimental effect of glutamate during 5-min ischemia. Some differentiated post-synaptic organization may act as a crucial factor in the development of ischemia-induced selective neuronal death in the gerbil hippocampus.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1351267     DOI: 10.1016/0306-4522(92)90492-k

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  20 in total

Review 1.  Calcium, energy metabolism and the development of selective neuronal loss following short-term cerebral ischemia.

Authors:  N R Sims
Journal:  Metab Brain Dis       Date:  1995-09       Impact factor: 3.584

2.  Orphenadrine prevents 3-nitropropionic acid-induced neurotoxicity in vitro and in vivo.

Authors:  D Pubill; E Verdaguer; A M Canudas; F X Sureda; E Escubedo; J Camarasa; M Pallàs; A Camins
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

3.  Acetylcholine becomes the major excitatory neurotransmitter in the hypothalamus in vitro in the absence of glutamate excitation.

Authors:  A B Belousov; B F O'Hara; J V Denisova
Journal:  J Neurosci       Date:  2001-03-15       Impact factor: 6.167

4.  Development of a novel micro biosensor for in vivo monitoring of glutamate release in the brain.

Authors:  Mallikarjunarao Ganesana; Elefterios Trikantzopoulos; Yash Maniar; Scott T Lee; B Jill Venton
Journal:  Biosens Bioelectron       Date:  2019-01-30       Impact factor: 10.618

5.  Reduced postischemic expression of a glial glutamate transporter, GLT1, in the rat hippocampus.

Authors:  R Torp; D Lekieffre; L M Levy; F M Haug; N C Danbolt; B S Meldrum; O P Ottersen
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

6.  Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices.

Authors:  T Frankiewicz; B Potier; Z I Bashir; G L Collingridge; C G Parsons
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

7.  Differential recovery of multimodal MRI and behavior after transient focal cerebral ischemia in rats.

Authors:  Kenneth M Sicard; Nils Henninger; Marc Fisher; Timothy Q Duong; Craig F Ferris
Journal:  J Cereb Blood Flow Metab       Date:  2006-03-15       Impact factor: 6.200

8.  Differential modification of the phospholipid profile by transient ischemia in rat hippocampal CA1 and CA3 regions.

Authors:  Kei Hamazaki; Hee-Yong Kim
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2013-02-07       Impact factor: 4.006

9.  Functional change of NMDA receptors related to enhancement of susceptibility to neurotoxicity in the developing pontine nucleus.

Authors:  A Mitani; M Watanabe; K Kataoka
Journal:  J Neurosci       Date:  1998-10-01       Impact factor: 6.167

10.  Pharmacodynamics of memantine: an update.

Authors:  G Rammes; W Danysz; C G Parsons
Journal:  Curr Neuropharmacol       Date:  2008-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.